Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.770
-0.010 (-0.26%)
At close: Jul 18, 2025, 4:00 PM
3.720
-0.050 (-1.33%)
After-hours: Jul 18, 2025, 4:00 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $68.95 million as of July 18, 2025. Its market cap has increased by 14.24% in one year.
Market Cap
68.95M
Enterprise Value
55.86M
1-Year Change
14.24%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $68.95M, a decrease of -66.97%. That is a compound annual growth rate of -26.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 69.14M | -13.10% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |